GELITA will showcase its latest breakthroughs at CPhI Worldwide 2025, taking place October 28-30 in Frankfurt, Germany.
At booth 3.0D37, visitors can experience first-hand how GELITA is driving the future of softgel technologies and bioscience applications.
As the recognised expert for softgel gelatin and collagen-based excipients, GELITA offers specialised solutions designed to meet today’s most demanding industry needs.
The softgel speciality portfolio includes solutions for revolutionary rapid fill release, enabling true enteric soft capsules, leak prevention or avoiding cross-linking.
These solutions offer pharma companies greater flexibility in formulation and improved stability for sensitive ingredients.
Endotoxin-controlled excipients for bioscience applications are specifically developed for advanced uses in vaccine stabilisation, 3D bioprinting, regenerative medicine and medical devices.
With stringent endotoxin control, these excipients support maximum safety and efficacy, opening up new pathways in drug delivery and biomedical engineering.
Visitors to GELITA’s booth will also benefit from direct engagement with experts from the GELITA Pharma Institute, who will be available for one-on-one consultations to help tailor solutions to individual project challenges.
As part of the programme, GELITA is also hosting a scientific lecture named "The Role of Non-Animal Recombinant Collagen Proteins in Biomedical Applications: From Vaccine Stabilisation to Artificial Organs".
This will be held on Tuesday, October 28th, 2025, at 1:30 PM